(Q84741524)

English

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series

scientific article published on 17 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Alexander Buchner

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Christian G Stief

11

object named as

Christian G Stief

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

13

object named as

Oliver Reich

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

object named as

Derya Tilki

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Christian Gratzke

6

object named as

Christian Gratzke

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Boris Schlenker

2

object named as

Boris Schlenker

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Süleyman Ergün

9

object named as

Süleyman Ergün

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ashutosh Tewari

10

object named as

Ashutosh K Tewari

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Majnu John

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Peter Stanislaus

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Alexander Karl

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Gerald Y Tan

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Michael Seitz

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

17 October 2009

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Urologic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

508-514

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

EAU guidelines on prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Prostate cancer volume at biopsy predicts clinically significant upgrading

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Hepatic resection: the last surgical frontier for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Evidence for a biopsy derived grade artifact among larger prostate glands

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Small Transrectal Ultrasound Volume Predicts Clinically Significant Gleason Score Upgrading After Radical Prostatectomy: Results From the SEARCH Database

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Comparison of transrectal ultrasound prostatic volume estimation with magnetic resonance imaging volume estimation and surgical specimen weight in patients with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Prostate biopsy grading errors: a sampling problem?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Active surveillance for prostate cancer: for whom?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

A single microfocus (5% or less) of Gleason 6 prostate cancer at biopsy--can we predict adverse pathological outcomes?

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.07.003

7 January 2021

Identifiers

10.1016/J.UROLONC.2009.07.003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19837614%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84741524&oldid=1755871715"